Arvinas (ARVN) Current Assets (2017 - 2026)

Arvinas' (ARVN) quarterly Current Assets came in at $630.7 million in Q1 2026, down 35.62% year-on-year from $979.7 million in Q1 2025, and down 9.99% quarter-over-quarter from $700.7 million in Q4 2025.

Arvinas (ARVN) Current Assets (2017 - 2026) Analysis & Trends

Arvinas' Current Assets history runs 10 years deep, the most recent figure standing at $630.7 million for Q1 2026.

  • On a quarterly basis, Current Assets fell 35.62% year-over-year to $630.7 million in Q1 2026; TTM through Mar 2026 was $630.7 million, a 35.62% decrease from a year earlier, with the FY2025 full-year figure at $700.7 million, down 34.35% from the prior year.
  • Current Assets fell to $630.7 million in Q1 2026 per ARVN's latest filing, from $700.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.5 billion in Q1 2022 and bottomed at $630.7 million in Q1 2026.
  • The 5-year median for Current Assets is $1.1 billion (2023), against an average of $1.1 billion.
  • Across the five-year window, Current Assets surged 119.26% in 2022 and tumbled 35.62% in 2026, its largest moves.
  • Year by year, Current Assets stood at $1.2 billion in 2022, then climbed by 3.23% to $1.3 billion in 2023, then fell by 16.63% to $1.1 billion in 2024, then tumbled by 34.35% to $700.7 million in 2025, then fell by 9.99% to $630.7 million in 2026.
  • Per Business Quant, the three latest ARVN Current Assets figures stand at $630.7 million (Q1 2026), $700.7 million (Q4 2025), and $826.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 289.93 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 73.04 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 6.60 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 521.86 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 8.07 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.97 Bn
10 Arvinas 519.68 Mn -95.22 Mn - 630.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 630.70 Mn
Dec 31, 2025 700.70 Mn
Sep 30, 2025 826.30 Mn
Jun 30, 2025 889.50 Mn
Mar 31, 2025 979.70 Mn
Dec 31, 2024 1.07 Bn
Sep 30, 2024 1.15 Bn
Jun 30, 2024 1.26 Bn
Mar 31, 2024 1.19 Bn
Dec 31, 2023 1.28 Bn
Sep 30, 2023 1.03 Bn
Jun 30, 2023 1.06 Bn
Mar 31, 2023 1.15 Bn
Dec 31, 2022 1.24 Bn
Sep 30, 2022 1.30 Bn
Jun 30, 2022 1.38 Bn
Mar 31, 2022 1.46 Bn
Dec 31, 2021 1.55 Bn
Sep 30, 2021 1.58 Bn
Jun 30, 2021 627.73 Mn